Stenotrophomonas maltophilia has been recognized as an emerging multi-drug resistant
opportunistic pathogen in cystic fibrosis (CF) patients. We report a comparative genomic and …

The present study was carried out to understand the adaptive strategies developed by
Stenotrophomonas maltophilia for chronic colonization of the cystic fibrosis (CF) lung. For …

Background Stenotrophomonas maltophilia is emerging as one of the most frequently found
bacteria in cystic fibrosis (CF) patients. In the present study, phenotypic and genotypic traits …

Background The potential pathogenic role of Stenotrophomonas maltophilia in lung disease
and in particular in cystic fibrosis is unclear. To develop further understanding of the biology …

Due to the continuous exposure to a challenging environment and repeated antibiotic
treatment courses, bacterial populations in cystic fibrosis (CF) patients experience selective …

Stenotrophomonas maltophilia is a Gram-negative bacterium found ubiquitously in the
environment that has historically been regarded as nonpathogenic. S. maltophilia is …

ABSTRACT The Stenotrophomonas maltophilia complex (Smc) comprises opportunistic
environmental Gram-negative bacilli responsible for a variety of infections in both humans …

Stenotrophomonas maltophilia is an emerging opportunistic respiratory pathogen in people
with cystic fibrosis (CF). S. maltophilia is frequently observed in polymicrobial infections, and …

The genetic relatedness of 52 Stenotrophomonas maltophilia strains, collected from various
environmental and clinical sources, including cystic fibrosis (CF) patients, as well as the …

Stenotrophomonas maltophilia is an emerging multidrug-resistant global opportunistic
pathogen. The increasing incidence of nosocomial and community-acquired S. maltophilia …